Mariah is a Berlin-based writer with six years of experience in writing, localizing and SEO-optimizing short- and long-form content across multiple niches, including higher education, digital ...

(RTTNews) - Enliven Therapeutics, Inc. (ELVN) shares jumped 50.86%, trading at $23.33, up $7.86, after the company reported positive initial Phase 1b data from its ENABLE clinical trial of ELVN-001 in ...

BOULDER, Colo., Jan. 8, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of ...